Elixxer Stock Performance
| ELIXF Stock | USD 0.03 0.00 0.00% |
Elixxer holds a performance score of 10 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -24.22, which means a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Elixxer are expected to decrease by larger amounts. On the other hand, during market turmoil, Elixxer is expected to outperform it. Use Elixxer coefficient of variation, maximum drawdown, as well as the relationship between the Maximum Drawdown and rate of daily change , to analyze future returns on Elixxer.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Elixxer are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Elixxer reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 2.1 M | |
| Total Cashflows From Investing Activities | 2.2 M | |
| Free Cash Flow | -4 M |
Elixxer |
Elixxer Relative Risk vs. Return Landscape
If you would invest 5.99 in Elixxer on November 7, 2025 and sell it today you would lose (2.64) from holding Elixxer or give up 44.07% of portfolio value over 90 days. Elixxer is currently producing 11.0877% returns and takes up 87.4156% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Elixxer, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Elixxer Target Price Odds to finish over Current Price
The tendency of Elixxer Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.03 | 90 days | 0.03 | about 51.18 |
Based on a normal probability distribution, the odds of Elixxer to move above the current price in 90 days from now is about 51.18 (This Elixxer probability density function shows the probability of Elixxer Pink Sheet to fall within a particular range of prices over 90 days) .
Elixxer Price Density |
| Price |
Predictive Modules for Elixxer
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Elixxer. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Elixxer's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Elixxer Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Elixxer is not an exception. The market had few large corrections towards the Elixxer's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Elixxer, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Elixxer within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 11.34 | |
β | Beta against Dow Jones | -24.22 | |
σ | Overall volatility | 0.02 | |
Ir | Information ratio | 0.12 |
Elixxer Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Elixxer for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Elixxer can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Elixxer is way too risky over 90 days horizon | |
| Elixxer has some characteristics of a very speculative penny stock | |
| Elixxer appears to be risky and price may revert if volatility continues | |
| Elixxer has high likelihood to experience some financial distress in the next 2 years | |
| Elixxer has accumulated 8.02 M in total debt with debt to equity ratio (D/E) of 1.6, which is about average as compared to similar companies. Elixxer has a current ratio of 0.64, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Elixxer until it has trouble settling it off, either with new capital or with free cash flow. So, Elixxer's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Elixxer sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Elixxer to invest in growth at high rates of return. When we think about Elixxer's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (3.66 M) with profit before overhead, payroll, taxes, and interest of 42.41 K. | |
| Elixxer has accumulated about 4.22 M in cash with (4.02 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.37, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 35.0% of Elixxer shares are held by company insiders |
Elixxer Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Elixxer Pink Sheet often depends not only on the future outlook of the current and potential Elixxer's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Elixxer's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 11.1 M | |
| Short Long Term Debt | 6.5 M | |
| Shares Float | 7.5 M |
Elixxer Fundamentals Growth
Elixxer Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Elixxer, and Elixxer fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Elixxer Pink Sheet performance.
| Return On Equity | -3.41 | |||
| Return On Asset | -0.031 | |||
| Operating Margin | (8.81) % | |||
| Current Valuation | 9.36 M | |||
| Shares Outstanding | 11.35 M | |||
| Price To Book | 2.45 X | |||
| Price To Sales | 139.36 X | |||
| EBITDA | (1.94 M) | |||
| Cash And Equivalents | 4.22 M | |||
| Cash Per Share | 0.37 X | |||
| Total Debt | 8.02 M | |||
| Debt To Equity | 1.60 % | |||
| Book Value Per Share | (0.22) X | |||
| Cash Flow From Operations | (4.02 M) | |||
| Earnings Per Share | (0.62) X | |||
| Total Asset | 16.84 M | |||
About Elixxer Performance
By analyzing Elixxer's fundamental ratios, stakeholders can gain valuable insights into Elixxer's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Elixxer has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Elixxer has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Elixxer Ltd. operates as a cannabis investment firm in Canada, Australia, Italy, Jamaica, and Switzerland. Elixxer Ltd. was incorporated in 2004 and is based in Montreal, Canada. Elixxer is traded on OTC Exchange in the United States.Things to note about Elixxer performance evaluation
Checking the ongoing alerts about Elixxer for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Elixxer help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Elixxer is way too risky over 90 days horizon | |
| Elixxer has some characteristics of a very speculative penny stock | |
| Elixxer appears to be risky and price may revert if volatility continues | |
| Elixxer has high likelihood to experience some financial distress in the next 2 years | |
| Elixxer has accumulated 8.02 M in total debt with debt to equity ratio (D/E) of 1.6, which is about average as compared to similar companies. Elixxer has a current ratio of 0.64, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Elixxer until it has trouble settling it off, either with new capital or with free cash flow. So, Elixxer's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Elixxer sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Elixxer to invest in growth at high rates of return. When we think about Elixxer's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (3.66 M) with profit before overhead, payroll, taxes, and interest of 42.41 K. | |
| Elixxer has accumulated about 4.22 M in cash with (4.02 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.37, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 35.0% of Elixxer shares are held by company insiders |
- Analyzing Elixxer's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Elixxer's stock is overvalued or undervalued compared to its peers.
- Examining Elixxer's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Elixxer's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Elixxer's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Elixxer's pink sheet. These opinions can provide insight into Elixxer's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Elixxer Pink Sheet analysis
When running Elixxer's price analysis, check to measure Elixxer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elixxer is operating at the current time. Most of Elixxer's value examination focuses on studying past and present price action to predict the probability of Elixxer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elixxer's price. Additionally, you may evaluate how the addition of Elixxer to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |